Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Treatment Effectiveness and Patient-Reported Outcome Measures of Four Treatment Options for OSA
abstract
This abstract is available on the publisher's site.
Access this abstract now Full Text Available for ClinicalKey SubscribersBACKGROUND
Continuous positive airway pressure (CPAP), mandibular advancement device (MAD), upper airway stimulation (UAS), and maxillomandibular advancement (MMA) are techniques to reduce apnea hypopnea index (AHI) in obstructive sleep apnea (OSA) patients. Current literature does not include a direct comparison of the 4 methods.
PURPOSE
The purpose of this study is to measure and compare the efficacy of 4 common OSA treatments: CPAP, MAD, UAS, MMA.
STUDY DESIGN, SETTING, SAMPLE
This retrospective cohort study examines data from 119 patients treated at Thomas Jefferson University Hospital in Philadelphia receiving CPAP, MAD, UAS, or MMA between January 2018 and December 2020. Patients were excluded for significant medical comorbidities, body mass index ≥45, cognitive limitations, central/mixed apnea history, or pregnancy.
PREDICTOR VARIABLES
The primary predictor variable was type of OSA intervention: CPAP, MAD, UAS, MMA. Treatments were assigned by treating physicians per their presenting OSA severity.
MAIN OUTCOME VARIABLES
The primary outcome variable was efficacy defined as the therapeutic response to treatment measured using mean disease alleviation, a calculated variable (percentage) which employs post-treatment AHI adjusted by compliance (a measure of a patient's device use). Secondary therapeutic measures included remaining AHI and patient-reported outcome measures: Epworth Sleepiness Scale, Sleep Apnea Quality of Life Index, Patient-reported Apnea Questionnaire.
COVARIATES
Demographic covariates included age, sex, height, weight, socioeconomic status, level of education, neck size, race, and body mass index. Clinical covariates included pretreatment AHI, AHI change, O2 nadir, adjusted compliance, and compliance.
ANALYSES
Multivariate statistics were computed with alpha level of 0.05, including a regression with the primary outcome variables, treatment variables, and potential covariates.
RESULTS
The sample included 119 subjects (mean age = 56.12, standard deviation [SD] = 5.81) with males at n = 72 (60%). MMA demonstrated greatest mean disease alleviation (M = 36.08, SD = 28.56), compared to UAS (M = 22.88, SD = 3.16), MAD (M = 6.80, SD = 8.13), and CPAP (M = 5.00, SD = 14.80), analysis of variance: P < .001.
CONCLUSION AND RELEVANCE
Both surgical treatments displayed significantly greater effectiveness than CPAP and MAD, suggesting that offering surgical alternatives sooner, particularly to those with severe OSA, may be logical in formulating more effective treatment guidelines.
Additional Info
Disclosure statements are available on the authors' profiles:
Comparing Treatment Effectiveness and Patient-Reported Outcome Measures of Four Treatment Options for Obstructive Sleep Apnea
J Oral Maxillofac Surg 2024 Aug 07;[EPub Ahead of Print], RJ Diecidue, MD LaNoue, EL Manning, CT Huntley, JD HarringtonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The medical and dental comorbidities of obstructive sleep apnea syndrome (OSAS) are significant and well-documented. The medical community is responsible for providing a gold-standard diagnosis via the polysomnogram. Yet, the question of the management or curative approach and the role of dentistry have been argued.
This study sought to compare the efficacy of four accepted interventions that included two nonsurgical approaches using continuous positive airway pressure, which pneumatically stents the airway open during sleep, and the mandibular advancement device, which mechanically opens the airway by pulling the genioglossus forward, preventing obstruction during sleep. Two surgical interventions were also included for the comparison — an upper airway stimulator and maxillomandibular advancement surgery — which may prevent dependence on an appliance during sleep, perhaps resulting in more of a curative outcome by reducing the apnea–hypopnea index (AHI) to what is considered within normal limits. Interestingly, two of the interventions, both surgical and nonsurgical, were each administered mainly by either a medical or dental provider.
Essential questions in assigning an intervention option are the severity of the disease measured by the AHI and compliance in using a device to manage any airflow limitation. Although the primary outcome measures were quantitatively measured via the change in the AHI, the secondary outcome measures were qualitative and necessary in measuring the clinical correlation, including quality-of-life measures. The authors found that the most significant finding of the study was the statistically significant improvement with both surgical interventions compared with nonsurgical interventions, as measured by the mean disease alleviation, which measures the change in the AHI as well as compliance.
Any sleep intervention must be considered in light of questions regarding patient preferences, risks, economics, long-term prognosis, and residual medical and dental comorbidities. Yet, very little consideration is given to diurnal breathing considerations, which have been well documented and are only improved via maxillomandibular surgery compared with the other three interventions considered in this study.
Lastly, the consideration of only providing a curative approach to patients suffering from the most severe disease ignores the known risk of a predicted future chronic disease with the progressive nature of sleep-disordered breathing and public health implications in the long term. As the authors suggested in their conclusions, “…impact of OSA on daily life might be beneficial in constructing a more useful set of treatment guidelines,” I couldn’t agree more.